In functional studies, we observed that both YPB and OPB peptides could disrupt YY1-EZH2 interaction, inhibit breast cancer cell proliferation, and reduce tumor formation, strongly suggesting the therapeutic potential of the two peptides in cancer treatments. The gene discussed is EZH2; the disease is neoplasm.